ResearcherTianjin Medical University Cancer Institute and HospitalActive in the last 2 years
Qingxiao Fang
Matched on ORCID iD 0009-0003-9116-6603; OpenAlex author ID A5055136010. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2025: 2 papers · 2026: 3 papers
Papers 5
- Sitagliptin, a repurposed diabetes drug, overcomes gemcitabine resistance in pancreatic cancer via ribonucleotide reductase inhibition: SITGEM-CARE phase 2 tri… Co-author DOI 10.1038/s41392-026-02966-0↗
- Rationally and in silico guided APOBEC3F-directed CBE for enhanced PDAC genetic therapy. Co-author DOI 10.1038/s42003-026-09770-0↗
- Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Mediated Metabolic-Epigenetic Rewiring. Co-author DOI 10.1158/2159-8290.cd-25-1627↗
- Targeting Mast Cell Activation and MIF-Mediated Remodelling Enhances Chemotherapy Response in Pancreatic Cancer. Co-author DOI 10.1002/advs.202509930↗
- The nuclear condensates of ESE3/EHF induce cellular senescence without the associated inflammatory secretory phenotype in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2024.217408↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tianxing Zhou · 4 shared papers, 2025–2026 · strength 0.86
- Paper Rationally and in silico guided APOBEC3F-directed CBE for enhanced PDAC genetic therapy. DOI 10.1038/s42003-026-09770-0↗
- Paper Targeting Mast Cell Activation and MIF-Mediated Remodelling Enhances Chemotherapy Response in Pancreatic Cancer. DOI 10.1002/advs.202509930↗
- Paper Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Me… DOI 10.1158/2159-8290.cd-25-1627↗
- Jihui Hao · 4 shared papers, 2025–2026 · strength 0.86
- Paper Rationally and in silico guided APOBEC3F-directed CBE for enhanced PDAC genetic therapy. DOI 10.1038/s42003-026-09770-0↗
- Paper Targeting Mast Cell Activation and MIF-Mediated Remodelling Enhances Chemotherapy Response in Pancreatic Cancer. DOI 10.1002/advs.202509930↗
- Paper Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Me… DOI 10.1158/2159-8290.cd-25-1627↗
- Jun Yu · 4 shared papers, 2025–2026 · strength 0.85
- Paper Rationally and in silico guided APOBEC3F-directed CBE for enhanced PDAC genetic therapy. DOI 10.1038/s42003-026-09770-0↗
- Paper Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Me… DOI 10.1158/2159-8290.cd-25-1627↗
- Paper Sitagliptin, a repurposed diabetes drug, overcomes gemcitabine resistance in pancreatic cancer via ribonucleotide reduc… DOI 10.1038/s41392-026-02966-0↗
- Yukuan Feng · 4 shared papers, 2025–2026 · strength 0.85
- Paper Rationally and in silico guided APOBEC3F-directed CBE for enhanced PDAC genetic therapy. DOI 10.1038/s42003-026-09770-0↗
- Paper Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Me… DOI 10.1158/2159-8290.cd-25-1627↗
- Paper Sitagliptin, a repurposed diabetes drug, overcomes gemcitabine resistance in pancreatic cancer via ribonucleotide reduc… DOI 10.1038/s41392-026-02966-0↗
- Yongjie Xie · 4 shared papers, 2025–2026 · strength 0.79
- Paper Targeting Mast Cell Activation and MIF-Mediated Remodelling Enhances Chemotherapy Response in Pancreatic Cancer. DOI 10.1002/advs.202509930↗
- Paper Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Me… DOI 10.1158/2159-8290.cd-25-1627↗
- Paper Sitagliptin, a repurposed diabetes drug, overcomes gemcitabine resistance in pancreatic cancer via ribonucleotide reduc… DOI 10.1038/s41392-026-02966-0↗
- Chao Yang · 3 shared papers, 2026 · strength 0.66
- Paper Rationally and in silico guided APOBEC3F-directed CBE for enhanced PDAC genetic therapy. DOI 10.1038/s42003-026-09770-0↗
- Paper Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Me… DOI 10.1158/2159-8290.cd-25-1627↗
- Paper Sitagliptin, a repurposed diabetes drug, overcomes gemcitabine resistance in pancreatic cancer via ribonucleotide reduc… DOI 10.1038/s41392-026-02966-0↗
- Xiuchao Wang · 3 shared papers, 2025–2026 · strength 0.59
- Paper Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Me… DOI 10.1158/2159-8290.cd-25-1627↗
- Paper Sitagliptin, a repurposed diabetes drug, overcomes gemcitabine resistance in pancreatic cancer via ribonucleotide reduc… DOI 10.1038/s41392-026-02966-0↗
- Paper The nuclear condensates of ESE3/EHF induce cellular senescence without the associated inflammatory secretory phenotype … DOI 10.1016/j.canlet.2024.217408↗
- Tiansuo Zhao · 3 shared papers, 2025–2026 · strength 0.59
- Paper Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Me… DOI 10.1158/2159-8290.cd-25-1627↗
- Paper Sitagliptin, a repurposed diabetes drug, overcomes gemcitabine resistance in pancreatic cancer via ribonucleotide reduc… DOI 10.1038/s41392-026-02966-0↗
- Paper The nuclear condensates of ESE3/EHF induce cellular senescence without the associated inflammatory secretory phenotype … DOI 10.1016/j.canlet.2024.217408↗
- Shangheng Shi · 2 shared papers, 2026 · strength 0.40
- Paper Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Me… DOI 10.1158/2159-8290.cd-25-1627↗
- Paper Sitagliptin, a repurposed diabetes drug, overcomes gemcitabine resistance in pancreatic cancer via ribonucleotide reduc… DOI 10.1038/s41392-026-02966-0↗
- Chongbiao Huang · 2 shared papers, 2025–2026 · strength 0.39
- Paper Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Me… DOI 10.1158/2159-8290.cd-25-1627↗
- Paper The nuclear condensates of ESE3/EHF induce cellular senescence without the associated inflammatory secretory phenotype … DOI 10.1016/j.canlet.2024.217408↗
- Shengyu Yang · 1 shared paper, 2026 · strength 0.20
- Zhi Ji · 1 shared paper, 2026 · strength 0.20
- Song Gao · 1 shared paper, 2026 · strength 0.20
- Libo Wang · 1 shared paper, 2025 · strength 0.20
- Yifei Wang · 1 shared paper, 2026 · strength 0.20
- Jing Liu · 1 shared paper, 2026 · strength 0.20
- Rui Liu · 1 shared paper, 2026 · strength 0.20
- Chuntao Gao · 1 shared paper, 2026 · strength 0.20
- Jihui Hao · 1 shared paper, 2026 · strength 0.20
- Weidong Ma · 1 shared paper, 2026 · strength 0.20
- Bin Wang · 1 shared paper, 2025 · strength 0.19
- Yiping Zou · 1 shared paper, 2025 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.